Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

04/13/07 Funding fears for new cancer drugs        

04/13/07 Brain cancer drugs approved in England        

04/13/07 Radiotherapy for Glioblastoma in the Elderly.        

04/10/07 Study: Localized radiation may work for some brain cancer patients        

04/09/07 Phase II trial of bevacizumab (Avastin) and irinotecan (CPT-11) in recurrent malignant glioma.        

04/09/07 Phase II trial of bevacizumab (Avastin) and irinotecan (CPT-11) in recurrent malignant glioma.        

03/30/07 Scientists seek £2m cancer laser        

03/29/07 NeoPharm plunges on FDA request        

03/29/07 Protherics starts trial of brain cancer therapy        

03/26/07 Erimos Pharmaceuticals Announces Phase I/Phase II Study of Terameprocol (EM-1421) In Conjunction with New Approaches to Brain Tumor Therapy (NABTT) Consortium        

03/23/07 Stanford brain tumor vaccine to be tested nationally        

03/22/07 Area doctor free of brain tumor for 22 months        

03/22/07 Decision Memo for Blood Brain Barrier Disruption (BBBD) Chemotherapy (CAG-00333N)        

03/20/07 New video on the mechanism of action of Gliadel Wafer added to video library        

03/16/07 Brain tumor talk scheduled for March 27, Seal Beach, California        

03/10/07 Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma.        

03/10/07 Complications of a temozolomide overdose: a case report.        

03/10/07 Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.        

03/10/07 Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma.        

---

Displaying Stories 3941 to 3960 of 7673
Previous 20           Next 20